Search

Your search keyword '"Wożakowska-Kapłon, Beata"' showing total 543 results

Search Constraints

Start Over You searched for: Author "Wożakowska-Kapłon, Beata" Remove constraint Author: "Wożakowska-Kapłon, Beata"
543 results on '"Wożakowska-Kapłon, Beata"'

Search Results

1. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

2. Therapeutic Strategies for Retinal Artery Occlusion—A Literature Review.

3. The Impact of a Single Haemodialysis Session on the Retinal Thickness and Optic Nerve Morphology

4. Can transesophageal echocardiography be safely omitted in patients scheduled for elective ablation of atrial arrhythmias? Data based on the LATTEE registry.

5. Bland-White-Garland syndrome in an asymptomatic adult individual: the role of imaging diagnostics in establishing a definitive diagnosis and preventing severe cardiac complications.

6. Oral anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish Multi-center Register of Atrial Fibrillation (POL-AF)

11. Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry

12. Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.

13. Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF).

16. Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?

17. Niewłaściwe przepisywanie zredukowanej dawki NOAC w praktyce klinicznej — wyniki Polskiego Rejestru Migotania Przedsionków (POL-AF) u hospitalizowanych pacjentów

20. Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society

22. Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience

24. Risk of left atrial appendage thrombus in older patients with atrial fibrillation.

25. Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

29. Rules for using reduced doses of non-vitamin K antagonist oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation. The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

30. The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society

31. Echocardiographic predictors of thrombus in left atrial appendage—The role of novel transthoracic parameters

34. Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry

36. Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

38. Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients—Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry

41. Differences in the predictors of left atrial appendage thrombus between men and women treated with dabigatran or rivaroxaban

44. Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort

45. Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019

46. Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease

48. Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot

49. An expert opinion of the Association of Cardiovascular Interventions and the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society related to the place of prasugrel in the prevention of cardiovascular events in patients with acute coronary syndromes

Catalog

Books, media, physical & digital resources